Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Repka

Showing results (171-180 of 755) with videos related to

Pageof 76
Sort By:
Ophthalmology|June 1, 1996
The one-year surgical outcome after prism adaptation for the management of acquired esotropiaM X Repka, J E Connett, W E Scott
International Journal of Pharmaceutics|September 1, 2004
Influence of human nail etching for the assessment of topical onychomycosis therapiesMichael A Repka, Praveen K Mididoddi, Steven P Stodghill
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 1, 1994
Treatment of acquired nystagmus with botulinum neurotoxin AM X Repka, P J Savino, R D Reinecke
Ophthalmology|April 1, 1991
A primate model of macular cystM X Repka, N M Bressler, S A D'Anna
Journal of Pharmaceutical Sciences|June 16, 2023
Development and Evaluation of Polymeric Mixed Micelles Prepared using Hot-Melt Extrusion for Extended Delivery of Poorly Water-Soluble DrugsSheng Feng, Ziru Zhang, Ahmed Almotairy, et al.
International Journal of Pharmaceutics|May 24, 2014
Continuous manufacturing of solid lipid nanoparticles by hot melt extrusionHemlata Patil, Vijay Kulkarni, Soumyajit Majumdar, et al.
JAMA Ophthalmology|February 20, 2015
Atropine vs Patching-ReplyMichael X Repka, Raymond T Kraker, Jonathan M Holmes, et al.
Ophthalmology. Retina|July 9, 2022
The Promise and Perils of Biosimilars in OphthalmologyGeorge A Williams, Michael X Repka, David B Glasser
American Journal of Ophthalmology|December 15, 1984
Pseudotumor cerebriM X Repka, N R Miller, P J Savino
Microbial Ecology|December 19, 2003
Associations of cyanobacterial toxin, nodularin, with environmental factors and zooplankton in the Baltic SeaS Repka, M Meyerhöfer, K von Bröckel, et al.
Pageof 76

Showing results (171-180 of 755) with videos related to

Sort By:
Pageof 76
Ophthalmology|June 1, 1996
The one-year surgical outcome after prism adaptation for the management of acquired esotropiaM X Repka, J E Connett, W E Scott
International Journal of Pharmaceutics|September 1, 2004
Influence of human nail etching for the assessment of topical onychomycosis therapiesMichael A Repka, Praveen K Mididoddi, Steven P Stodghill
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 1, 1994
Treatment of acquired nystagmus with botulinum neurotoxin AM X Repka, P J Savino, R D Reinecke
Ophthalmology|April 1, 1991
A primate model of macular cystM X Repka, N M Bressler, S A D'Anna
Journal of Pharmaceutical Sciences|June 16, 2023
Development and Evaluation of Polymeric Mixed Micelles Prepared using Hot-Melt Extrusion for Extended Delivery of Poorly Water-Soluble DrugsSheng Feng, Ziru Zhang, Ahmed Almotairy, et al.
International Journal of Pharmaceutics|May 24, 2014
Continuous manufacturing of solid lipid nanoparticles by hot melt extrusionHemlata Patil, Vijay Kulkarni, Soumyajit Majumdar, et al.
JAMA Ophthalmology|February 20, 2015
Atropine vs Patching-ReplyMichael X Repka, Raymond T Kraker, Jonathan M Holmes, et al.
Ophthalmology. Retina|July 9, 2022
The Promise and Perils of Biosimilars in OphthalmologyGeorge A Williams, Michael X Repka, David B Glasser
American Journal of Ophthalmology|December 15, 1984
Pseudotumor cerebriM X Repka, N R Miller, P J Savino
Microbial Ecology|December 19, 2003
Associations of cyanobacterial toxin, nodularin, with environmental factors and zooplankton in the Baltic SeaS Repka, M Meyerhöfer, K von Bröckel, et al.
Pageof 76